Literature DB >> 23452505

Angry affect and violence in the context of a psychotic illness: a systematic review and meta-analysis of the literature.

Shuja Reagu1, Roland Jones, Veena Kumari, Pamela J Taylor.   

Abstract

A small but significant relationship between schizophrenia and violence is well established, but not yet fully explained. Research has highlighted anger as an important factor in precipitating actual violence in general and psychiatric populations. However, anger has not been extensively studied as a risk factor for violence in people with schizophrenia and related psychoses. We evaluated published evidence on the relationship between anger and violence in patients with schizophrenia and related psychoses by means of a systematic review of the literature. A search of main online databases from inception till January 2012 was performed and supplemented with correspondence with authors and data available online. 11 studies which measured angry affect in patients with schizophrenia who had been violent were included in the review. 5 studies with a total of 510 individuals had anger data that were suitable to be pooled in a meta-analysis in form of standardised mean difference values comparing the anger scores of the non-violent groups with violent groups. All the studies included showed significantly higher scores for anger in the violent group compared with the non-violent group with the pooled result expressed as standardised mean difference of 0.74 95% CI (0.53, 0.94) and the Z value for overall effect=7.01. The studies not included in the meta-analysis which looked at 610 individuals, were analysed descriptively and all of them reported higher scores for anger for individuals with schizophrenia who acted violently. There is a consistency of significant association between angry affect and violent behaviour in the context of psychotic illness across various study designs, settings and populations. Theoretical support already exists for this relationship and this review lends further support to explore this relationship further.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23452505     DOI: 10.1016/j.schres.2013.01.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  A cross sectional study of prevalence and correlates of current and past risks in schizophrenia.

Authors:  Kiran Jakhar; Triptish Bhatia; Rahul Saha; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2015-02-03

2.  The Violent Content in Attenuated Psychotic Symptoms.

Authors:  Catherine Marshall; Stephanie Deighton; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

3.  Pylons ablaze: Examining the role of 5G COVID-19 conspiracy beliefs and support for violence.

Authors:  Daniel Jolley; Jenny L Paterson
Journal:  Br J Soc Psychol       Date:  2020-06-21

4.  Using citation network analysis to enhance scholarship in psychological science: A case study of the human aggression literature.

Authors:  Alessia Iancarelli; Thomas F Denson; Chun-An Chou; Ajay B Satpute
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.752

5.  Aberrant Functional Connectivity of the Orbitofrontal Cortex Is Associated With Excited Symptoms in First-Episode Drug-Naïve Patients With Schizophrenia.

Authors:  Congxin Chen; Jingjing Yao; Yiding Lv; Xiaoxin Zhao; Xinyue Zhang; Jiaxi Lei; Yuan Li; Yuxiu Sui
Journal:  Front Psychiatry       Date:  2022-07-28       Impact factor: 5.435

6.  Anterior cingulate hyperactivations during negative emotion processing among men with schizophrenia and a history of violent behavior.

Authors:  Andràs Tikàsz; Stéphane Potvin; Ovidiu Lungu; Christian C Joyal; Sheilagh Hodgins; Adrianna Mendrek; Alexandre Dumais
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-15       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.